Literature DB >> 26938992

A vision of KIR variation at super resolution.

John A Hammond1, Mary Carrington2,3, Salim I Khakoo4.   

Abstract

The Ninth Killer Cell Immunoglobulin-Like Receptor (KIR) Workshop was held in Winchester, UK late in the summer of 2015. The extraordinary diversity of KIR and its functional consequences were key themes throughout the meeting. Novel sequencing technologies and new bioinformatics techniques continue to increase our understanding of the genetic diversity and evolution of the KIR; while a deeper understanding of KIR functions, including their specificity for MHC and its peptide ligands, are generating more refined models of their role in disease. Limited to 100 delegates from around the world, this intimate workshop facilitated vigorous discussion, generating new ideas for research in this ever-expanding field. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  inhibitory/activating receptors; killer cell immunoglobulin-like receptors; natural killer cells

Mesh:

Substances:

Year:  2016        PMID: 26938992      PMCID: PMC4913283          DOI: 10.1111/imm.12606

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  7 in total

1.  Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

Authors:  N Wagtmann; R Biassoni; C Cantoni; S Verdiani; M S Malnati; M Vitale; C Bottino; L Moretta; A Moretta; E O Long
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

2.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

Authors:  M Colonna; J Samaridis
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

3.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

4.  Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Authors:  Sarah Cooley; Elizabeth Trachtenberg; Tracy L Bergemann; Koy Saeteurn; John Klein; Chap T Le; Steven G E Marsh; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller; Daniel J Weisdorf
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

5.  Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.

Authors:  A D'Andrea; C Chang; K Franz-Bacon; T McClanahan; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

6.  A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia.

Authors:  Annettee Nakimuli; Olympe Chazara; Susan E Hiby; Lydia Farrell; Stephen Tukwasibwe; Jyothi Jayaraman; James A Traherne; John Trowsdale; Francesco Colucci; Emma Lougee; Robert W Vaughan; Alison M Elliott; Josaphat Byamugisha; Pontiano Kaleebu; Florence Mirembe; Neda Nemat-Gorgani; Peter Parham; Paul J Norman; Ashley Moffett
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

7.  Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype.

Authors:  J E Gumperz; N M Valiante; P Parham; L L Lanier; D Tyan
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

  7 in total
  7 in total

Review 1.  Nomenclature report for killer-cell immunoglobulin-like receptors (KIR) in macaque species: new genes/alleles, renaming recombinant entities and IPD-NHKIR updates.

Authors:  Jesse Bruijnesteijn; Natasja G de Groot; Nel Otting; Giuseppe Maccari; Lisbeth A Guethlein; James Robinson; Steven G E Marsh; Lutz Walter; David H O'Connor; John A Hammond; Peter Parham; Ronald E Bontrop
Journal:  Immunogenetics       Date:  2019-11-29       Impact factor: 2.846

2.  Activating KIR2DS4 Is Expressed by Uterine NK Cells and Contributes to Successful Pregnancy.

Authors:  Philippa R Kennedy; Olympe Chazara; Lucy Gardner; Martin A Ivarsson; Lydia E Farrell; Shiqiu Xiong; Susan E Hiby; Francesco Colucci; Andrew M Sharkey; Ashley Moffett
Journal:  J Immunol       Date:  2016-11-04       Impact factor: 5.422

Review 3.  KIR, LILRB and their Ligands' Genes as Potential Biomarkers in Recurrent Implantation Failure.

Authors:  Izabela Nowak; Karolina Wilczyńska; Jacek R Wilczyński; Andrzej Malinowski; Paweł Radwan; Michał Radwan; Piotr Kuśnierczyk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-05-18       Impact factor: 4.291

Review 4.  The role of KIR and HLA interactions in pregnancy complications.

Authors:  Francesco Colucci
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

Review 5.  The IPD Project: a centralised resource for the study of polymorphism in genes of the immune system.

Authors:  Giuseppe Maccari; James Robinson; John A Hammond; Steven G E Marsh
Journal:  Immunogenetics       Date:  2019-10-22       Impact factor: 2.846

6.  ERAP, KIR, and HLA-C Profile in Recurrent Implantation Failure.

Authors:  Karolina Piekarska; Paweł Radwan; Agnieszka Tarnowska; Andrzej Wiśniewski; Michał Radwan; Jacek R Wilczyński; Andrzej Malinowski; Izabela Nowak
Journal:  Front Immunol       Date:  2021-10-22       Impact factor: 7.561

7.  Nomenclature for the KIR of non-human species.

Authors:  James Robinson; Lisbeth A Guethlein; Giuseppe Maccari; Jeroen Blokhuis; Benjamin N Bimber; Natasja G de Groot; Nicholas D Sanderson; Laurent Abi-Rached; Lutz Walter; Ronald E Bontrop; John A Hammond; Steven G E Marsh; Peter Parham
Journal:  Immunogenetics       Date:  2018-06-04       Impact factor: 2.846

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.